David Llewellyn Takes Helm as CEO at Trailhead Biosystems

Beachwood, OH, May 20, 2025 (PRNewswire) -- Trailhead Biosystems has appointed David Llewellyn, PhD, MBA, as its new CEO, marking a pivotal transition as the company shifts focus toward commercialization. Founding CEO Jan Jensen, PhD, will remain as Chief Scientific Officer to continue advancing the company’s HD-DoE® stem cell platform. Llewellyn’s extensive leadership experience in life sciences is expected to drive Trailhead’s expansion in regenerative medicine and drug discovery.

Read full article here.